Electro-Optical Sciences Announces Participation at the ROTH 20th Annual OC Growth Stock Conference
IRVINGTON, NY--(Marketwire - January 28, 2008) - Electro-Optical Sciences, Inc. ("EOS")
(NASDAQ: MELA), a medical device company focused on the design and
development of MelaFind®, a non-invasive, point-of-care instrument to
assist in the early diagnosis of melanoma, today announced that Joseph V.
Gulfo, MD, MBA, president and chief executive officer, will present at the
ROTH 20th Annual OC Growth Stock Conference taking place at The Ritz
Carlton, Laguna Niguel, in Dana Point, CA February 18 - 21, 2008.
Dr. Gulfo's presentation is scheduled for Tuesday, February 19 at 11:30am
PT, 2:30pm ET. To access the live webcast of this presentation visit
www.eosciences.com. A replay of this presentation will be available on the
company's website for thirty days following the presentation.
About Electro-Optical Sciences
Electro-Optical Sciences is a medical device company focused on designing
and developing a non-invasive, point-of-care instrument to assist in the
early diagnosis of melanoma. MelaFind®, EOS's flagship product, features
a hand-held imaging device that emits light of multiple wavelengths to
capture images of suspicious pigmented skin lesions and extract data. Using
sophisticated algorithms, the data are then analyzed against a proprietary
database of melanomas and benign lesions in order to provide information to
the physician and produce a recommendation of whether the lesion should be
Melanoma is the deadliest of skin cancers, responsible for approximately
80% of all skin cancer deaths. Unless melanoma is detected early and
excised with proper margins, the patient survival rate is poor, as there is
currently no cure for advanced stage melanoma.
For more information on EOS, visit www.eosciences.com.
This press release includes "forward-looking statements" within the meaning
of the Securities Litigation Reform Act of 1995. These statements include
but are not limited to our plans, objectives, expectations and intentions
and other statements that contain words such as "expects," "contemplates,"
"anticipates," "plans," "intends," "believes" and variations of such words
or similar expressions that predict or indicate future events or trends, or
that do not relate to historical matters. These statements are based on our
current beliefs or expectations and are inherently subject to significant
uncertainties and changes in circumstances, many of which are beyond our
control. There can be no assurance that our beliefs or expectations will be
achieved. Actual results may differ materially from our beliefs or
expectations due to economic, business, competitive, market and regulatory
Contact Information: For further information contact:
Lazar Partners Ltd.